Ex Parte HAIK - Page 6


                    Appeal No.  2002-1874                                                                     Page 6                        
                    Application No.  09/079,329                                                                                             


                    Examiner’s Answer, page 4.                                                                                              
                            Appellant argues that one of ordinary skill in the art would understand the                                     
                    meaning of “blocking.”  Appeal Brief, page 3.  We agree.                                                                
                            The test for definiteness is whether one skilled in the art would understand                                    
                    the bounds of the claim when read in light of the specification.”  Miles                                                
                    Laboratories, Inc. v. Shandon, Inc., 997 F.2d 870, 875, 27 USPQ2d 1123, 1126                                            
                    (Fed. Cir. 1993).  Claims are in compliance with 35 U.S.C. § 112, second                                                
                    paragraph, if “the claims, read in light of the specification, reasonably apprise                                       
                    those skilled in the art and are as precise as the subject matter permits.”                                             
                    Hybritech, Inc. v. Monoclonal Antibodies, Inc., 802 F.2d 1367, 1385, 231 USPQ                                           
                    81, 94-95 (Fed. Cir. 1987).                                                                                             
                            The specification makes clear that the D-arginine of the method blocks                                          
                    the carbonyl containing compounds by means of a covalent bond.  For example,                                            
                    the paragraph bridging pages 5 and 6 of the specification states:                                                       
                                     It is an object therefore of the present invention to provide a                                        
                            method of removing toxic carbonyls and/or dicarbonyls, for                                                      
                            example from a living body by administering a therapeutically                                                   
                            effective dose of L- and/or D-arginine or an arginine-containing                                                
                            compound to a living body, the arginine thereby chemically reacting                                             
                            with the carbonyl group and preventing its reaction with native                                                 
                            tissues.                                                                                                        
                    (emphasis added).                                                                                                       
                            Because one skilled in the art would understand  “blocking” to mean                                             
                    blocking by covalent reaction, the rejection is reversed.                                                               
                    3.      35 U.S.C. § 103(a)                                                                                              






Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007